Literature DB >> 7506987

Exogenous prostacyclin, but not prostaglandin E2, produces similar responses in both G6PD activity and RNA production as mechanical loading, and increases IGF-II release, in adult cancellous bone in culture.

S C Rawlinson1, S Mohan, D J Baylink, L E Lanyon.   

Abstract

Cyclic mechanical loading in vivo that leads to new bone formation is also associated in osteocytes and surface bone cells with almost immediate increases in G6PD activity, and later increases in RNA production. Both these early, loading-related, responses can be reproduced in organ culture of adult cancellous bone, and both are abolished by the presence of indomethacin in the culture medium at the time of loading. The implication that prostaglandins (PGs) are involved in the control of loading-related osteogenesis is supported by increases in prostacyclin (PGI2) and PGE2 release from cores of cancellous bone during loading. In the experiments reported here, PGE2 and PGI2 were added exogenously (10(-6) M) to perfusable cores of adult canine cancellous bone to determine whether they would simulate the loading-related responses in G6PD activity and RNA synthesis. PGE2 increased G6PD activity in surface cells and osteocytes within 8 minutes but had no effect on [3H]-uridine incorporation at 6 hours. PGI2 stimulated both G6PD activity and [3H]-uridine incorporation equally in osteocytes and surface cells. Neither PG produced any significant change in medium concentrations of IGF-I, and PGE2 had no effect on IGF-II. In contrast PGI2 elevated the medium concentration of IGF-II threefold. IGF-I and IGF-II were localized immunocytochemically to osteocytes and surface cells in both treated and untreated cores. Prostacyclin, but not PGE2, appears to imitate the early loading-related increases in G6PD activity and RNA synthesis in bone cells in situ. Prostacyclin, but not PGE2, also stimulates the early release of IGF-II.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506987     DOI: 10.1007/bf01351837

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  36 in total

1.  Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone.

Authors:  T L McCarthy; M Centrella; L G Raisz; E Canalis
Journal:  Endocrinology       Date:  1991-06       Impact factor: 4.736

2.  1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts.

Authors:  S H Scharla; D D Strong; S Mohan; D J Baylink; T A Linkhart
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

3.  Increased 3H-uridine levels in osteocytes following a single short period of dynamic bone loading in vivo.

Authors:  M J Pead; R Suswillo; T M Skerry; S Vedi; L E Lanyon
Journal:  Calcif Tissue Int       Date:  1988-08       Impact factor: 4.333

4.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease.

Authors:  K Ueda; A Saito; H Nakano; M Aoshima; M Yokota; R Muraoka; T Iwaya
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

5.  Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.

Authors:  W S Jee; S Mori; X J Li; S Chan
Journal:  Bone       Date:  1990       Impact factor: 4.398

6.  The transduction of mechanical force into biochemical events in bone cells may involve activation of phospholipase A2.

Authors:  I Binderman; U Zor; A M Kaye; Z Shimshoni; A Harell; D Sömjen
Journal:  Calcif Tissue Int       Date:  1988-04       Impact factor: 4.333

7.  Early strain-related changes in cultured embryonic chick tibiotarsi parallel those associated with adaptive modeling in vivo.

Authors:  S L Dallas; G Zaman; M J Pead; L E Lanyon
Journal:  J Bone Miner Res       Date:  1993-03       Impact factor: 6.741

8.  Local stimulation of new bone formation by prostaglandin E1: quantitative histomorphometry and comparison of delivery by minipumps and controlled-release pellets.

Authors:  S C Miller; S C Marks
Journal:  Bone       Date:  1993 Mar-Apr       Impact factor: 4.398

9.  Constitutive synthesis of insulin-like growth factor-II by primary osteoblast-enriched cultures from fetal rat calvariae.

Authors:  T L McCarthy; M Centrella; E Canalis
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

10.  Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease.

Authors:  D P Desimone; V S Greene; K S Hannon; R T Turner; N H Bell
Journal:  J Bone Miner Res       Date:  1993-05       Impact factor: 6.741

View more
  10 in total

1.  Experimental studies of bone mechanoadaptation: bridging in vitro and in vivo studies with multiscale systems.

Authors:  Genevieve N Brown; Rachel L Sattler; X Edward Guo
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

2.  Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone.

Authors:  Zachary C Ryan; Theodore A Craig; Jeffrey L Salisbury; Lomeli R Carpio; Meghan McGee-Lawrence; Jennifer J Westendorf; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-04-26       Impact factor: 3.575

Review 3.  Mechanotransduction and the functional response of bone to mechanical strain.

Authors:  R L Duncan; C H Turner
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

4.  Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats.

Authors:  M Machwate; E Zerath; X Holy; M Hott; D Godet; A Lomri; P J Marie
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

Review 5.  Role of insulin-like growth factor-1 in the regulation of skeletal growth.

Authors:  Subburaman Mohan; Chandrasekhar Kesavan
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

6.  Bone marrow stromal cells are load responsive in vitro.

Authors:  G P Thomas; A J el Haj
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

7.  In situ microdialysis in bone tissue. Stimulation of prostaglandin E2 release by weight-bearing mechanical loading.

Authors:  K Thorsen; A O Kristoffersson; U H Lerner; R P Lorentzon
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

Review 8.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

9.  Loading-related regulation of transcription factor EGR2/Krox-20 in bone cells is ERK1/2 protein-mediated and prostaglandin, Wnt signaling pathway-, and insulin-like growth factor-I axis-dependent.

Authors:  Gul Zaman; Andrew Sunters; Gabriel L Galea; Behzad Javaheri; Leanne K Saxon; Alaa Moustafa; Victoria J Armstrong; Joanna S Price; Lance E Lanyon
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

Review 10.  The molecular basis of bone mechanotransduction.

Authors:  M P Yavropoulou; J G Yovos
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-09-07       Impact factor: 2.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.